SKIN BARRIER PRODUCTS MARKET ANALYSIS

Skin Barrier Products Market, By Product Type (Foam Applicator, Spray, Wipes, Tapes & Strips, and Others), By Indication (Urinary or Fecal Incontinence, Ostomy Management, Medical Adhesive-related Skin Injury (MARSI), Moisture-Associated Skin Damage (MASD), and Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home-care Settings, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Published In : Apr 2024
Code : CMI4962
Pages :167
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Global Skin Barrier Products Market – Impact of the Coronavirus (COVID-19) Pandemic

The coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared the COVID-19 a pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 399 million cases and 5.75 million deaths due to coronavirus disease (COVID-19) were reported up till February 9, 2022, across the globe.

Impact of COVID-19 on Demand and Supply of Skin Barrier Products

The COVID-19 pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses across all sectors including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; 3) through its financial impact on companies and financial markets. Many countries such as Thailand, Indonesia, and Singapore are facing problems with regard to the transportation and distribution of healthcare products.

The COVID-19 caused significant disruption to the delivery of patient care across the globe, including ostomy management or stoma care. For instance, according to an article published in the British Journal of Nursing in September 2020, the number of face-to-face appointments and home visits of patients with a stoma and an ileo-anal pouch at Oxford University Hospitals NHS Foundation Trust decreased significantly between April and June 2020, causing difficulties for patients in ostomy management.